Verve Therapeutics, Inc. Insider Transactions
Verve Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Ashe Andrew D.
See Remarks |
Buy | 76,000 @ $6.26 | $475,760 | 342,509 | 05/14/2024 | 05/15/2024 | |
|
Nickerson Joan
Chief Administrative Officer |
Sell | 1,514 @ $8.24 | $12,475 | 8,659 | 04/02/2024 | 04/03/2024 | |
|
Yeshwant Krishna
Director, 10 percent owner: |
Buy | 1,800,000 @ $10.00 | $18.00 M | 1,800,000 | 12/01/2023 | 12/05/2023 | |
|
Dorval Allison
CFO |
Sell | 554 @ $11.45 | $6,343 | 4,060 | 11/29/2023 | 12/01/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Verve Therapeutics, Inc. FAQ's
The list of insiders at Verve Therapeutics, Inc. includes Nickerson Joan, Ashe Andrew D..
Insiders have sold a total of 1,514 Verve Therapeutics, Inc. shares in the last 12 months for a total of 12,475 sold.
The following insiders have sold Verve Therapeutics, Inc. shares in the last 12 months: Nickerson Joan ($12,475),
Insiders have purchased a total of 76,000 Verve Therapeutics, Inc. shares in the last 12 months for a total of 475,760.
The following insiders have purchased Verve Therapeutics, Inc. shares in the last 12 months: Ashe Andrew D. ($475,760),